EXELON 1,5mg
Generic Name: rivastigmine
Pill imprint EXELON 1,5mg has been identified as Exelon 1.5 mg.
Exelon is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy.
Exelon 1.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Exelon Images
- Generic Name:
- rivastigmine
- Imprint:
-
EXELON 1,5mg
- Strength:
- 1.5 mg
- Color:
- Yellow
- Size:
- 1.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0323
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4512 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Exelon resources
- Exelon
- Exelon (Wolters Kluwer)
- Exelon Patch (Wolters Kluwer)
- Exelon Solution (Wolters Kluwer)
- Exelon (Cerner Multum)
- Exelon (Micromedex) - Includes Dosage Information
- Exelon Transdermal (Micromedex) - Includes Dosage Information
- Exelon (AHFS DI)
- Exelon (FDA)
- Exelon Patch (FDA)


